Mitoxantrone in the treatment of relapse
✍
P. Meyer; A. D. Ho; G. Ehninger; I. Mjaaland; E. Heidemann; E. Seither
📂
Article
📅
1985
🏛
Springer US
🌐
English
⚖ 245 KB
Twenty-four patients with acute leukemia or blast crisis (BC) of chronic myelocytic leukemia (CML) in relapse or refractory to standard chemotherapy, were eligible for treatment with mitoxantrone. Mitoxantrone (Novantrone| dihydroxyanthracenedione) was administered in a dose of 8-13 mg/m 2 on five c